References
- 1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS et al. Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. DOI: 10.1016/S1473-3099(18)30605-410.1016/S1473-3099(18)30605-4
- 2. Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S et al. Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. Elife. 2016;6: pii: e18082. DOI: 10.7554/eLife.1808210.7554/eLife.18082503009627599374
- 3. Mazzariol A, Bazaj A, Cornaglia G. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J Chemother. 2017;29(1):2-9. DOI: 10.1080/1120009X.2017.138039510.1080/1120009X.2017.138039529271736
- 4. Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P et al. Antimicrobial resistance in Escherichia coli. Microbiol Spectr. 2018;6(4): ARBA-0026-2017. DOI: 10.1128/microbiolspec.ARBA-0026-201710.1128/microbiolspec.ARBA-0026-201730003866
- 5. Vila J, Sáez-López E, Johnson JR, Römling U, Dobrindt U, Cantón R et al. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016;40(4):437-63. DOI: 10.1093/femsre/fuw00510.1093/femsre/fuw00528201713
- 6. Gillings MR. Integrons: past, present, and future. Microbiol Mol Biol Rev. 2014;78:257-77. DOI: 10.1128/MMBR.00056-1310.1128/MMBR.00056-13405425824847022
- 7. Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31(4): pii: e00088-17. DOI: 10.1128/CMR.00088-1710.1128/CMR.00088-17614819030068738
- 8. Deng Y, Bao X, Ji L, Chen L, Liu J, Miao J et al. Resistance integrons: class 1, 2 and 3 integrons. Ann Clin Microbiol Antimicrob. 2015;20:14:45. DOI: 10.1186/s12941-015-0100-610.1186/s12941-015-0100-6461827726487554
- 9. Lacotte Y, Ploy MC, Raherison S. Class 1 integrons are low-cost structures in Escherichia coli. ISME J. 2017;11(7):1535-44. DOI: 10.1038/ismej.2017.3810.1038/ismej.2017.38552015628387772
- 10. Kaushik M, Kumar S, Kapoor RK, Virdi JS, Gulati P. Integrons in Enterobacteriaceae: diversity, distribution and epidemiology. Int J Antimicrob Agents. 2018;51(2):167-76. DOI: 10.1016/j.ijantimicag.2017.10.00410.1016/j.ijantimicag.2017.10.00429038087
- 11. Cristea VC, Oprea M, Neacşu G, Gîlcă R, Popa MI, Usein CR. Mechanisms of resistance to ciprofloxacin and genetic diversity of Escherichia coli strains originating from urine cultures performed for Romanian adults. Roum Arch Microbiol Immunol. 2015;74(3-4):73-8.
- 12. Xu H, Davies J, Miao V. Molecular characterization of class 3 integrons from Delftia spp. J Bacteriol. 2007;189(17):6276-83. DOI: 10.1128/JB.00348-0710.1128/JB.00348-07195191317573473
- 13. Lévesque C, Piché L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995;39(1):185-191. DOI: 10.1128/AAC.39.1.18510.1128/AAC.39.1.1851625077695304
- 14. Machado E, Ferreira J, Novais A, Peixe L, Cantón R, Baquero F et al. Preservation of integron types among Enterobacteriaceae producing extended-spectrum beta-lactamases in a Spanish hospital over a 15-year period (1988 to 2003). Antimicrob Agents Chemother. 2007;51(6):2201-04. DOI: 10.1128/AAC.01389-0610.1128/AAC.01389-06189139417404002
- 15. Străuț M, Dinu S, Oprea M, Drãgulescu EC, Lixandru BE, Surdeanu M. Genetic diversity of structures surrounding bla genes identified in Pseudomonas aeruginosa clinical isolates from Bucharest, Romania. Roum Arch Microbiol Immunol. 2018; 77(1):16-27.
- 16. Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother. 2004;48(12):4654-61. DOI: 10.1128/AAC.48.12.4654-4661.200410.1128/AAC.48.12.4654-4661.200452918915561840
- 17. Untergasser A, Cutcutache I, Koressaar T, Ye J, Fair-cloth BC, Remm M, et al. Tm calculation and software from Primer3--new capabilities and interfaces. Nucleic Acids Res. 2012;40(15:e115. DOI: 10.1093/nar/gks59610.1093/nar/gks596342458422730293
- 18. Dawes FE, Kuzevski A, Bettelheim KA, Hornitzky MA, Djordjevic SP, Walker MJ. Distribution of class 1 integrons with IS26-mediated deletions in their 3’-conserved segments in Escherichia coli of human and animal origin. PLoS One. 2010;5(9):e12754. DOI: 10.1371/journal.pone.001275410.1371/journal.pone.0012754293987120856797
- 19. Liu YG, Chen Y. High-efficiency thermal asymmetric interlaced PCR for amplification of unknown flanking sequences. Biotechniques. 2007;43(5):649-50. DOI: 10.2144/00011260110.2144/00011260118072594
- 20. Tsafnat G, Copty J, Partridge SR. RAC: Repository of Antibiotic-resistance Cassettes. Database 2011;bar054. DOI: 10.1093/database/bar05410.1093/database/bar054322920722140215
- 21. Díaz-Mejía JJ, Amábile-Cuevas CF, Rosas I, Souza V. An analysis of the evolutionary relationships of integron integrases, with emphasis on the prevalence of class 1 integrons in Escherichia coli isolates from clinical and environmental origins. Microbiology. 2008;154:94-102. DOI: 10.1099/mic.0.2007/008649-010.1099/mic.0.2007/008649-018174129
- 22. Oliveira-Pinto C, Diamantino C, Oliveira PL, Reis MP, Costa PS, Paiva MC et al. Occurrence and characterization of class 1 integrons in Escherichia coli from healthy individuals and those with urinary infection. J Med Microbiol. 2017;66(5):577-83. DOI: 10.1099/jmm.0.00046810.1099/jmm.0.00046828485709
- 23. Leverstein-van Hall MA, M Blok HE, T Donders AR, Paauw A, Fluit AC, Verhoef J. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis. 2003;187(2):251-9. DOI: 10.1086/34588010.1086/34588012552449
- 24. Mooij MJ, Schouten I, Vos G, Van Belkum A, Vandenbroucke-Grauls CM, Savelkoul PH et al. Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals. Clin Microbiol Infect. 2005;11(11):898-902. DOI: 10.1111/j.1469-0691.2005.01259.x10.1111/j.1469-0691.2005.01259.x16216105
- 25. Rao AN, Barlow M, Clark LA, Boring JR 3rd, Tenover FC, McGowan JE Jr. Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg Infect Dis. 2006;12(6):1011-4. DOI: 10.3201/eid1206.05159610.3201/eid1206.051596337305716707065
- 26. Stephenson SA, Brown PD. Occurrence of class 1 integrons in uropathogenic fluoroquinolone-resistant clinical Escherichia coli isolates from Jamaica. APMIS. 2013;121(3):226-31. DOI: 10.1111/j.1600-0463.2012.02960.x10.1111/j.1600-0463.2012.02960.x23030058
- 27. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A. 2002;99(8):5638-42. DOI: 10.1073/pnas.08209289910.1073/pnas.08209289912282311943863
- 28. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47(7):2242-8. DOI: 10.1128/AAC.47.7.2242-2248.200310.1128/AAC.47.7.2242-2248.200316183412821475
- 29. Yang H, Chen H, Yang Q, Chen M, Wang H. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6’)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Anti-microb Agents Chemother. 2008;52(12):4268-73. DOI: 10.1128/AAC.00830-0810.1128/AAC.00830-08259287718809939
- 30. El-Najjar NG, Farah MJ, Hashwa FA, Tokajian ST. Antibiotic resistance patterns and sequencing of class I integron from uropathogenic Escherichia coli in Lebanon. Lett Appl Microbiol. 2010;51(4):456-61. DOI: 10.1111/j.1472-765X.2010.02926.x10.1111/j.1472-765X.2010.02926.x20840552
- 31. Zeighami H, Haghi F, Masumian N, Hemmati F, Samei A, Naderi G. Distribution of integrons and gene cassettes among uropathogenic and diarrheagenic Escherichia coli isolates in Iran. Microb Drug Resist. 2015;21(4):435-40. DOI: 10.1089/mdr.2014.014710.1089/mdr.2014.014725658172
- 32. Sunde M, Simonsen GS, Slettemeås JS, Böckerman I, Norström M. Integron, plasmid and host strain characteristics of Escherichia coli from humans and food included in the Norwegian antimicrobial resistance monitoring programs. PLoS One. 2015;10(6):e0128797. DOI: 10.1371/journal.pone.012879710.1371/journal.pone.0128797445780926047499
- 33. Skurnik D, Le Menac’h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Chemother. 2005;49(7):3062-5. DOI: 10.1128/AAC.49.7.3062-3065.200510.1128/AAC.49.7.3062-3065.2005116862915980401
- 34. Post V, Recchia GD, Hall RM. Detection of gene cassettes in Tn402-like class 1 integrons. Antimicrob Agents Chemother. 2007;51(9):3467-8. DOI: 10.1128/AAC.00220-0710.1128/AAC.00220-07204317617591852
- 35. Vinué L, Sáenz Y, Somalo S, Escudero E, Moreno MA, Ruiz-Larrea F, Torres C. Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain. J Antimicrob Chemother. 2008;62(5):934-7. DOI: 10.1093/jac/dkn33110.1093/jac/dkn33118708645
- 36. Sáenz Y, Vinué L, Ruiz E, Somalo S, Martínez S, Rojo-Bezares B et al. Class 1 integrons lacking qacEDelta1 and sul1 genes in Escherichia coli isolates of food, animal and human origins. Vet Microbiol. 2010;144(3-4):493-7. DOI: 10.1016/j.vetmic.2010.01.02610.1016/j.vetmic.2010.01.02620176451
- 37. Rijavec M, Starcic Erjavec M, Ambrozic Avgustin J, Reissbrodt R, Fruth A, Krizan-Hergouth V et al. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol. 2006;53(2):158-62. DOI: 10.1007/s00284-005-0501-410.1007/s00284-005-0501-416802204
- 38. Ochoa SA, Cruz-Córdova A, Luna-Pineda VM, Reyes-Grajeda JP, Cázares-Domínguez V, Escalona G et al. Multidrug- and extensively drug-resistant uropathogenic Escherichia coli clinical strains: Phylogenetic groups widely associated with integrons maintain high genetic diversity. Front Microbiol. 2016;7:2042. DOI: 10.3389/fmicb.2016.0204210.3389/fmicb.2016.02042517408228066364
- 39. Kõljalg S, Truusalu K, Stsepetova J, Pai K, Vainumäe I, Sepp E et al. The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent uri-nary tract infections. APMIS 2014;122(5):452-458. DOI: 10.1111/apm.1216710.1111/apm.1216724033434
- 40. Poey ME, Lavi-a M. Integrons in uropathogenic Escherichia coli and their relationship with phylogeny and virulence. Microb Pathog. 2014;77:73-7. DOI: 10.1016/j.micpath.2014.11.00210.1016/j.micpath.2014.11.00225448130